The stock's fall snapped a three-day winning streak.

Zoetis Inc. closed 21.60% short of its 52-week high of $200.33, which the company reached on September 19th.

Zoetis's leadership, scale, and innovation position it well against new competitors. Click here to read more about ZTS stock ...

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, August 5, 2025. Chief Executive ...

Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term ...

The two healthcare companies below generally deliver excellent returns and dividend growth. Consider the following two ...

dvm360 connects veterinarians to essential medical news, veterinary expertise, and insights on pet care products and ...

I remain positive on Phibro's long-term prospects and would look to buy on dips, as structural improvements appear sustainable. Read more on PAHC stock here.

Zoetis's ZTS Get Free Report short percent of float has fallen 17.72% since its last report. The company recently reported that it has 8.69 million shares sold short, which is 1.95% of all regular ...

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, August 5, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial ...